Modelling hepatotoxicity and antiretroviral therapeutic effect in HIV/HBV coinfection
From MaRDI portal
Publication:1989670
DOI10.1016/j.mbs.2018.05.012zbMath1400.92324OpenAlexW2803210447WikidataQ56910951 ScholiaQ56910951MaRDI QIDQ1989670
Hasifa Nampala, Joseph Y. T. Mugisha, Matylda Jablonska-Sabuka, Celestino Obua, Livingstone S. Luboobi
Publication date: 26 October 2018
Published in: Mathematical Biosciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.mbs.2018.05.012
Related Items (4)
Modeling the effect of vaccination and treatment on the transmission dynamics of hepatitis B virus and HIV/AIDS coinfection ⋮ Mathematical Model of HBV/HCV Co-Infection ⋮ Stationary distribution and density function analysis of a stochastic epidemic HBV model ⋮ Mathematical analysis of the role of HIV/HBV latency in hepatocytes
Cites Work
- Unnamed Item
- Unnamed Item
- Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model
- Dynamics of HIV infection of CD4\(^ +\) T cells
- Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
- Mathematical modeling of liver enzyme elevation in HIV mono-infection
- Modeling the mechanisms of acute hepatitis B virus infection
- Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility
- Rich dynamics of a hepatitis B viral infection model with logistic hepatocyte growth
- Predicting the potential impact of a cytotoxic T-lymphocyte HIV vaccine: How often should you vaccinate and how strong should the vaccine be?
- Modeling the dynamics of HIV and \(CD4^{+}\)T cells during primary infection
- Descartes' Rule of Signs Revisited
- Immune Responses and Viral Phenotype: Do Replication Rate and Cytopathogenicity Influence Virus Load?
- A New Mathematical Model for Assessing Therapeutic Strategies for HIV Infection
This page was built for publication: Modelling hepatotoxicity and antiretroviral therapeutic effect in HIV/HBV coinfection
